Zylö Therapeutics

Greenville, United States

Zylö Therapeutics offers an innovative sustained-release drug-delivery system.

$294K raised

May 2023

Grant

Health Care Pharmaceutical Therapeutics

Top Investors

New York Angels VentureSouth SC Launch Inc.Chemical Angel Network Harvard Business School Alumni Angels of Greater NY

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Zylö Therapeutics

How much funding has Zylö Therapeutics raised?

Zylö Therapeutics has raised $294K in total funding. The most recent round was Grant. The last funding was announced in May 2023.

Who are Zylö Therapeutics's investors?

Zylö Therapeutics's investors include New York Angels, VentureSouth, SC Launch, Inc., Chemical Angel Network, Harvard Business School Alumni Angels of Greater NY.

Where is Zylö Therapeutics headquartered?

Zylö Therapeutics is headquartered in Greenville, United States.

What does Zylö Therapeutics do?

Zylö Therapeutics offers an innovative sustained-release drug-delivery system.

What stage is Zylö Therapeutics at?

Zylö Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 31, 2023.

MLA

"Zylö Therapeutics — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/zyl-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Zylö Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/zyl-therapeutics

Wikipedia (cite web)

{{cite web |title=Zylö Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/zyl-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 31, 2023.